246 related articles for article (PubMed ID: 18427357)
1. Body size affects measures of ovarian reserve in late reproductive age women.
Su HI; Sammel MD; Freeman EW; Lin H; DeBlasis T; Gracia CR
Menopause; 2008; 15(5):857-61. PubMed ID: 18427357
[TBL] [Abstract][Full Text] [Related]
2. Utility of serum antimüllerian hormone/Müllerian-inhibiting substance for predicting ovarian reserve in older women.
Berin I; Teixeira J
Menopause; 2008; 15(5):824-6. PubMed ID: 18600185
[No Abstract] [Full Text] [Related]
3. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women.
De Pergola G; Maldera S; Tartagni M; Pannacciulli N; Loverro G; Giorgino R
Obesity (Silver Spring); 2006 Nov; 14(11):1954-60. PubMed ID: 17135611
[TBL] [Abstract][Full Text] [Related]
4. Impact of cancer therapies on ovarian reserve.
Gracia CR; Sammel MD; Freeman E; Prewitt M; Carlson C; Ray A; Vance A; Ginsberg JP
Fertil Steril; 2012 Jan; 97(1):134-40.e1. PubMed ID: 22137491
[TBL] [Abstract][Full Text] [Related]
5. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age.
Steiner AZ; Pritchard D; Stanczyk FZ; Kesner JS; Meadows JW; Herring AH; Baird DD
JAMA; 2017 Oct; 318(14):1367-1376. PubMed ID: 29049585
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of some ovarian reserve tests in poor responders.
Vladimirov IK; Tacheva DM; Kalinov KB; Ivanova AV; Blagoeva VD
Arch Gynecol Obstet; 2005 Jun; 272(1):74-9. PubMed ID: 15660265
[TBL] [Abstract][Full Text] [Related]
7. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of three-dimensional SonoAVC ultrasound for antral follicle count in infertile women: its agreement with conventional two-dimensional ultrasound and serum levels of anti-Müllerian hormone.
Peres Fagundes PA; Chapon R; Olsen PR; Schuster AK; Mattia MMC; Cunha-Filho JS
Reprod Biol Endocrinol; 2017 Dec; 15(1):96. PubMed ID: 29246176
[TBL] [Abstract][Full Text] [Related]
9. Antimullerian hormone and obesity: insights in oral contraceptive users.
Steiner AZ; Stanczyk FZ; Patel S; Edelman A
Contraception; 2010 Mar; 81(3):245-8. PubMed ID: 20159182
[TBL] [Abstract][Full Text] [Related]
10. Does obesity compromise ovarian reserve markers? A clinician's perspective.
Malhotra N; Bahadur A; Singh N; Kalaivani M; Mittal S
Arch Gynecol Obstet; 2013 Jan; 287(1):161-6. PubMed ID: 22930149
[TBL] [Abstract][Full Text] [Related]
11. Cycle and hormone changes during perimenopause: the key role of ovarian function.
Burger HG; Hale GE; Dennerstein L; Robertson DM
Menopause; 2008; 15(4 Pt 1):603-12. PubMed ID: 18574431
[TBL] [Abstract][Full Text] [Related]
12. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound.
Deb S; Campbell BK; Pincott-Allen C; Clewes JS; Cumberpatch G; Raine-Fenning NJ
Ultrasound Obstet Gynecol; 2012 May; 39(5):574-80. PubMed ID: 21997961
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of ovarian reserve in women with obesity in reproductive period.
Grigoryan OR; Mikheev RK; Andreeva EN; Dedov II
Ter Arkh; 2018 Nov; 90(10):30-34. PubMed ID: 30701792
[TBL] [Abstract][Full Text] [Related]
14. Ovarian primordial and nongrowing follicle counts according to the Stages of Reproductive Aging Workshop (STRAW) staging system.
Hansen KR; Craig LB; Zavy MT; Klein NA; Soules MR
Menopause; 2012 Feb; 19(2):164-71. PubMed ID: 22189385
[TBL] [Abstract][Full Text] [Related]
15. Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients.
Su HC; Haunschild C; Chung K; Komrokian S; Boles S; Sammel MD; DeMichele A
Cancer; 2014 Dec; 120(23):3691-8. PubMed ID: 25081546
[TBL] [Abstract][Full Text] [Related]
16. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.
Knauff EA; Eijkemans MJ; Lambalk CB; ten Kate-Booij MJ; Hoek A; Beerendonk CC; Laven JS; Goverde AJ; Broekmans FJ; Themmen AP; de Jong FH; Fauser BC;
J Clin Endocrinol Metab; 2009 Mar; 94(3):786-92. PubMed ID: 19066296
[TBL] [Abstract][Full Text] [Related]
17. Prenatal determinants of uterine volume and ovarian reserve in adolescence.
Hart R; Sloboda DM; Doherty DA; Norman RJ; Atkinson HC; Newnham JP; Dickinson JE; Hickey M
J Clin Endocrinol Metab; 2009 Dec; 94(12):4931-7. PubMed ID: 19846735
[TBL] [Abstract][Full Text] [Related]
18. Is ovarian reserve associated with body mass index and obesity in reproductive aged women? A meta-analysis.
Moslehi N; Shab-Bidar S; Ramezani Tehrani F; Mirmiran P; Azizi F
Menopause; 2018 Sep; 25(9):1046-1055. PubMed ID: 29738413
[TBL] [Abstract][Full Text] [Related]
19. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
20. Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women.
Wunder DM; Bersinger NA; Yared M; Kretschmer R; Birkhäuser MH
Fertil Steril; 2008 Apr; 89(4):927-33. PubMed ID: 17603052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
